Applied Therapeutics ( (APLT) ) has released a notification of late filing.
Applied Therapeutics, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for the delay is the ongoing preparation of analyses necessary to complete year-end financial reporting procedures. Additionally, the company identified a material weakness in its internal control over financial reporting, specifically related to deficiencies in the information and communication component of the COSO framework. Applied Therapeutics expects to file the Form 10-K within the fifteen calendar-day period permitted by Rule 12b-25. The company does not anticipate any significant changes in its financial results from the previous fiscal year. The notification includes forward-looking statements, emphasizing that actual results may differ due to various risks and uncertainties. The company is actively working on compliance efforts to address the identified issues, with the notification signed by Les Funtleyder, Interim Chief Executive Officer and Chief Financial Officer.
More about Applied Therapeutics
YTD Price Performance: -42.54%
Average Trading Volume: 3,579,249
Technical Sentiment Signal: Buy
Current Market Cap: $60.07M
For detailed information about APLT stock, go to TipRanks’ Stock Analysis page.